Ketamine hydrochloride, an anesthetic medication, has been demonstrated to acutely and rapidly improve depressive symptoms but not yet been adequately studied for this effect when used as part of a general anesthetic for surgery.
This proposed single-centre, double-blinded, randomized clinical trial of adult patients with depression presenting for gynecologic surgery would compare severity of depressive symptoms between patients receiving and not receiving ketamine as part of their general anesthetic.
Topic Depression
Country Canada
Visit trial
Status
Unknown status
Results Published
Start date
12 January 2018
End date
12 January 2019
Phase
Phase IV
Design
Blinded
Type
Interventional
Generation
First
Participants
50
Sex
Female
Age
18- 65
Therapy
No
Trial Details
Ketamine hydrochloride, an anesthetic medication, has been demonstrated to acutely and rapidly improve depressive symptoms but not yet been adequately studied for this effect when used as part of a general anesthetic for surgery. This proposed single-centre, double-blinded, randomized clinical trial of adult patients with depression presenting for gynecologic surgery would compare severity of depressive symptoms between patients receiving and not receiving ketamine as part of their general anesthetic.Trial Number NCT03666494
Sponsors & Collaborators
University of SaskatchewanThe University of Saskatchewan is a research-intensive, medical doctoral university in Canada which famously hosted Humphrey Osmond in the 1950s.
Saskatoon Health Region
This company doesn't have a full profile yet, it is linked to a clinical trial.
Royal University Hospital Foundation
This company doesn't have a full profile yet, it is linked to a clinical trial.